NOTICE OF INTENT TO SOLE SOURCE - PREVENTION GENETICS

The purpose of this acquisition is to perform genetic analysis related to congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency at the Pediatrics department at the National Institutes of Health Clinical Center.

•            Product Service Code: 6515 – Medical Instruments, Equipment, and Supplies

•            NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing

•            Place of Performance: Bethesda, MD 20892 USA

POTS: 25-010421

Description:

This is a notice of intent, not a request for a quotation.  A solicitation document will not be issued and quotations will not be requested.

The National Institutes of Health (NIH) intends to award a fixed price purchase order to Prevention Genetics. LLC, located at 3800 S Business Park Ave, Marshfield, WI 54449, on a firm fixed price sole source award basis to provide Accreditation on-site evaluation services to the National Institutes of Health.

Prevention Genetics is also the only commercial laboratory that evaluates the TNXB gene and identifies specific chimeric genes associated with CAH-X. They do full sequencing of both the CYP21A2 and TNXB genes, as well as 18 genes involved in EDS. This is an important aspect of our ongoing research.

This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available.  Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.

Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.

Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by September 24, 2025 at 2pm EST.